[go: up one dir, main page]

WO1997016167A1 - Preparations cosmetiques - Google Patents

Preparations cosmetiques Download PDF

Info

Publication number
WO1997016167A1
WO1997016167A1 PCT/EP1996/004617 EP9604617W WO9716167A1 WO 1997016167 A1 WO1997016167 A1 WO 1997016167A1 EP 9604617 W EP9604617 W EP 9604617W WO 9716167 A1 WO9716167 A1 WO 9716167A1
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
preparations
fatty acid
sulfosuccinates
surfactants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1996/004617
Other languages
German (de)
English (en)
Inventor
Catherine Le Hen Ferrenbach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Priority to EP96934806A priority Critical patent/EP0858320A1/fr
Publication of WO1997016167A1 publication Critical patent/WO1997016167A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
    • C09K23/02—Alkyl sulfonates or sulfuric acid ester salts derived from monohydric alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents

Definitions

  • the invention relates to cosmetic agents containing selected sulfosuccinates and their use in the manufacture of cosmetic agents.
  • Sulfosuccinates are anionic surfactants which, in addition to outstanding technical properties, also have a particularly high level of ecotoxicological compatibility. For these reasons, sulfosuccinates are widely used today for producing hand dishwashing detergents and, in particular, cosmetic products for which foaming power and skin tolerance are two decisive parameters. Nevertheless, there is a constant need in the market for products with further improved properties and, in particular, increased dermatological compatibility, in order to be able to satisfy customers who are particularly easily prone to skin and mucous membrane irritations.
  • the object of the invention was to provide new cosmetic compositions based on sulfosuccinates, which are characterized by significantly improved dermatological compatibility with at least consistently good foaming power.
  • the invention relates to cosmetic compositions containing sulfosuccinates of the formula (I),
  • R represents a behenyl radical
  • R represents R or Mg and m and n independently of one another represent 0 or numbers from 1 to 10.
  • sulfosuccinate magnesium salts based on behenyl alcohols or behenyl alcohol ethoxylates not only have a particularly strong foaming power, but at the same time also have a very high tolerance to the mucous membrane. These two properties make the products interesting for use in a variety of cosmetic products.
  • Sulfosuccinates which are also referred to as sulfosuccinic acid esters, are known anionic surfactants which can be obtained by the relevant methods of preparative organic chemistry.
  • maleic acid but preferably maleic anhydride
  • the first step with optionally ethoxylated primary alcohols.
  • the mono / diester ratio can be adjusted by varying the amount of alcohol and the temperature.
  • bisulfite is added, which is usually carried out in the solvent methanol. More recent reviews of the manufacture and use of sulfosuccinates are, for example, from T. Schoenberg in Cosm. Toil. 104, 105 (1989), J.A.
  • Typical examples are sulfosuccinic acid mono- and / or dibehenyl esters in the form of their magnesium salts; the behenyl alcohol can be etherified with an average of 1 to 10 and preferably 1 to 5 moles of ethylene oxide, both conventional and preferably have a narrow homolog distribution.
  • Examples include di-n-behenyl sulfosuccinate and monobehenyl + 3EO sulfosuccinate in the form of their magnesium salts.
  • the preparations according to the invention can contain further anionic, nonionic, cationic and / or amphoteric or zwitterionic surfactants.
  • anionic surfactants are alkylbenzene sulfonates, alkane sulfonates, olefin sulfonates, alkyl ether sulfonates, glycerol ether sulfonates, ⁇ -methyl ester sulfonates, sulfo fatty acids, alkyl sulfates, fatty alcohol ether sulfates, glycerol ether sulfates, hydroxymixed ether sulfates, amine sulfide ether, mono sulfide ether fatty acid, monoglyl glyceride fatty acids, mono sulfide ether sulfate, monoglyl glyceride, fatty acid (mono sulfide ether), mono sulfide ether fatty acid, mono sulfide ether, mono sulfide ether, mono sulfide ether fatty acid, mono
  • nonionic surfactants are fatty alcohol polyglycol ethers, alkylphenol polyglycol ethers, fatty acid polyglycol esters, fatty acid amide polyglycol ethers, fatty amine polyglycol ethers, alkoxylated triglycerides, mixed ethers or mixed formals, alkyl oligoglucosides, fatty acid N-alkylglucamides, protein hydrolysates, especially vegetable hydrolysates, especially vegetable hydrolysates, especially vegetable hydrolysates, sugar hydrolysates, especially vegetable hydrolysates, especially vegetable hydrolysates, especially vegetable hydrolysates, especially vegetable hydrolysates, especially vegetable hydrolysates, especially vegetable hydrolysates, especially vegetable hydrolysates, especially vegetable hydrolysates, Sorbitan esters, polysorbates and amine oxides. If the nonionic surfactants contain polyglycol ether chains, they can have a conventional, but preferably a narrow, homolog distribution.
  • cationic surfactants are quaternary ammonium compounds and ester quats, in particular quaternized fatty acid trialkanolamine ester salts.
  • amphoteric or zwitterionic surfactants are alkyl betaines, alkyl amido betaines, amino propionates, aminoglycinates, imidazolinium betaines and sulfobetaines.
  • the surfactants mentioned are exclusively known compounds. With regard to the structure and manufacture of these substances, see relevant reviews for example J.Falbe (ed.), “Surfactants in Consumer Products”, Springer Verlag, Berlin, 1987, pp. 54-124 or J.Falbe (ed.), “Catalysts, Surfactants and Mineral Oil Additives”, Thieme Verlag, Stuttgart, 1978, pp. 123-217.
  • the preparations according to the invention are distinguished by a high foaming power and a particularly advantageous tolerance to the mucous membrane.
  • Another object of the invention therefore relates to the use of the sulfosuccinates mentioned at the outset for the production of cosmetic preparations, in which they can be present in amounts of 1 to 50, preferably 5 to 35% by weight, based on the composition.
  • the solids content of these compositions is likewise usually 5 to 55% by weight and preferably 15 to 35% by weight.
  • the preparations can contain, as further auxiliaries and additives, emulsifiers, superfatting agents, thickeners, cation polymers, silicone compounds, biogenic active substances, film formers, preservatives, colorants and fragrances contain.
  • the proportion of the sulfosuccinates in the cosmetic compositions can be 1 to 55, preferably 5 to 35% by weight, based on the preparations.
  • Nonionic, ampholytic and / or zwitterionic surface-active compounds which are distinguished by a lipophilic, preferably linear alkyl or alkenyl group and at least one hydrophilic group can be used as emulsifiers or co-emulsifiers.
  • This hydrophilic group can be both an ionogenic and a nonionic group.
  • Non-ionic emulsifiers contain as a hydrophilic group z.
  • Preferred agents are those which contain nonionic surfactants from at least one of the following groups as OAV emulsifiers: (al) addition products of 2 to 30 mol of ethylene oxide and / or 0 to 5 mol of propylene oxide onto linear fatty alcohols having 8 to 22 carbon atoms , on fatty acids with 12 to 22 C atoms and on alkylphenols with 8 to 15 C atoms in the alkyl group; (a2) C 12 / i 8 fatty acid monoesters and diesters of addition products of 1 to 30 mol ethylene oxide onto glycerol; (a3) glycerol monoesters and diesters and sorbitan monoesters and diesters of saturated and unsaturated fatty acids having 6 to 22 carbon atoms and their ethylene oxide addition products; (a4) alkyl mono- and oligoglycosides with 8 to 22 carbon atoms in the alkyl radical and their ethoxylated analogues and (a5) addition products of 15 to
  • adducts of ethylene oxide and / or of propylene oxide with fatty alcohols, fatty acids, alkylphenols, glycerol mono- and diesters as well as sorbitan mono- and diesters of fatty acids or with castor oil are known, commercially available products. whose average degree of alkoxylation corresponds to the ratio of the amounts of ethylene oxide and / or propylene oxide and substrate with which the addition reaction is carried out.
  • C ⁇ 2 / i 8 fatty acid monoesters and diesters of adducts of ethylene oxide with glycerol are known from DE-PS 20 24 051 as refatting agents for cosmetic preparations.
  • Cg / ⁇ 8 - alkyl mono- and oligoglycosides their preparation and their use as surface-active substances are, for example, from US 3,839,318, US 3,707,535, US 3,547,828, DE-OS 19 43 689, DE-OS 20 36 472 and DE-Al 30 01 064 and EP-A 0 077 167 are known. They are produced in particular by reacting glucose or oligosaccharides with primary alcohols with 8 to 18 carbon atoms.
  • glycoside residue both monoglycosides in which a cyclic sugar residue is glycosidically bonded to the fatty alcohol and oligomeric glycosides with a degree of oligomerization of up to preferably about 8 are suitable.
  • the degree of oligomerization is a statistical mean value which is based on a homolog distribution customary for such technical products.
  • Zwitterionic surfactants can also be used as emulsifiers. Zwitterionic surfactants are surface-active compounds that contain at least one quaternary ammonium group and at least one carboxylate and one sulfonate group in the molecule.
  • Particularly suitable zwitterionic surfactants are the so-called betaines such as the N-alkyl-N, N-dimethylammonium glycinate, for example the coconut alkyl dimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinate, for example the coconut acylaminopropyldimethylammonium glycinate, and 2-alkylyl 1- 3-carboxy-1-methyl-3-hydroxyethylimidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group and the cocoacylaminoethylhydroxyethylcarboxymethylglycinate.
  • betaines such as the N-alkyl-N, N-dimethylammonium glycinate, for example the coconut alkyl dimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinate
  • fatty acid amide derivative known under the CTFA name Cocamidopropyl Betaine is particularly preferred.
  • Suitable emulsifiers are ampholytic surfactants.
  • Ampholytic surfactants are surface-active compounds which, in addition to a Cg / 18 alkyl or acyl group, contain at least one free amino group and at least one -COOH or -SO 3 H group in the molecule and are capable of forming internal salts.
  • ampholytic surfactants are N-alkylglycine, N-alkylpropionic acid, N-alkylaminobutyric acid, N-alkyliminodipropionic acid, N-hydroxyethyl-N-alkylamidopropylglycine, N-alkyltaurine, N-alkyl sarcosine, 2-alkylaminopropionic acid and alkylaminoacetic acid each about 8 to 18 carbon atoms in the alkyl group.
  • Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C 12 / lg -acyl sarcosine.
  • Possible W / O emulsifiers are: (b1) adducts of 2 to 15 moles of ethylene oxide with castor oil and / or hardened castor oil; (b2) partial esters based on linear, branched, unsaturated or saturated C 12-2 fatty acids, ricinoleic acid and 12-hydroxystearic acid and glycerol, polyglycerol, pentaerythritol, dipentaerythritol, sugar alcohols (eg sorbitol) and polyglucosides (eg cellulose); (b3) trialkyl phosphates; (b4) wool wax alcohols; (b5) polysiloxane-polyalkyl-polyether copolymers or corresponding derivatives; (b6) mixed esters of pentaerythritol, fatty acids, citric acid and fatty alcohol according to DE-PS 11 65574 and (b7) polyalkylene glycols.
  • Substances such as, for example, polyethoxylated lanolin derivatives, lecithin derivatives, polyol fatty acid esters, monoglycerides and fatty acid alkanolamides can be used as superfatting agents, the latter simultaneously serving as foam stabilizers.
  • Suitable thickeners are, for example, polysaccharides, in particular xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl cellulose, and also higher molecular weight polyethylene glycol mono- and diesters of fatty acids, polyacrylates, polyvinyl alcohol and polyvinylpyrrolidone, surfactants such as, for example, fatty alcohol alcohol ethoxylates with a narrow homolog distribution or alkyl oligoglucosides as well as electrolytes such as table salt and ammonium chloride.
  • polysaccharides in particular xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl cellulose, and also higher molecular weight polyethylene glycol mono- and diesters of fatty acids, polyacrylates, polyvinyl alcohol and polyvinylpyrrolidone
  • Suitable cationic polymers are, for example, cationic cellulose derivatives, cationic starch, copolymers of diallylammonium salts and acrylamides, quaternized vinylpyrrolidone / vinylimidazole polymers such as e.g. Luviquat® (BASF AG, Ludwigshafen / FRG), condensation products of polyglycols and amines, quaternized collagen polypeptides such as lauryldimonium hydroxypropyl hydrolyzed collagen (Lamequat®L, Grünau GmbH), polyethyleneimine, cationic silicone polymers such as e.g.
  • Amidomethicone or Dow Corning, Dow Corning Co./US copolymers of adipic acid and dimethylaminohydroxypropyldiethylenetrimamine (Cartaretine®, Sandoz / CH), polyamino polyamides such as e.g. described in FR-A 22 52 840 and its crosslinked water-soluble polymers, cationic chitin derivatives such as quaternized chitosan, optionally microcrystalline, cationic guar gum such as e.g. Jaguar® CBS, Jaguar® C-17, Jaguar® C-16 from Celanese / US, quaternized ammonium salt polymers such as Mirapol® A-15, Mirapol® AD-1, Mirapol® AZ-1 from Miranol / US.
  • Suitable silicone compounds are, for example, dimethylpolysiloxanes, methylphenylpolysiloxanes, cyclic silicones and amino, fatty acid, alcohol, polyether, epoxy, fluorine and / or alkyl modified silicone compounds.
  • Biogenic active substances are understood to mean, for example, plant extracts and vitamin complexes.
  • Common film formers are, for example, chitosan, microcrystalline chitosan, quaternized chitosan, polyvinylpyrrolidone, vinylpyrrolidone-vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives, collagen, hyaluronic acid or its salts and similar compounds.
  • Suitable preservatives are, for example, phenoxyethanol, formaldehyde solution, parabens, pentanediol or sorbic acid.
  • Suitable pearlizing agents are, for example, glycol distearic acid esters such as ethylene glycol distearate, but also fatty acid monoglycol esters.
  • the dyes which can be used are the substances which are suitable and approved for cosmetic purposes, as compiled, for example, in the publication "Cosmetic Dyes" by the Dye Commission of the German Research Foundation, Verlag Chemie, Weinheim, 1984, pp. 81-106. This - 8th -
  • Dyes are usually used in concentrations of 0.001 to 0.1% by weight, based on the mixture as a whole.
  • the total proportion of auxiliaries and additives can be 1 to 50, preferably 5 to 40,% by weight, based on the composition.
  • the foaming power was determined according to the Ross Miles Test (DIN 53 902, Part II) at a temperature of 20 ° C and a water hardness of 16 ° d.
  • the amount of surfactants used was 1 g of active substance / 1.
  • the dermatological tolerance was assessed on the chorionallantoic membrane of the incubated chicken egg (HET-CAM), which represents a model for the tolerance of a substance to the eye mucosa.
  • the cytotoxicity was determined relative to a comparative product of the trade.
  • the example formulations 1 to 4 are according to the invention, the example formulations VI to V4 are used for comparison.
  • the composition of the formulations and cytotoxicity and foam levels are summarized in Table 1 (percentages as% by weight).
  • Texapon® SB3 Laureth-3 Sulfosuccinate Sodium Salt
  • Plantaren® APG 1200 dodecyl polyglucose
  • Gluadin® WQ Wheat Hydrolyzed Proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne de nouveaux agents cosmétiques qui contiennent des sulfosuccinates de la formule (I), dans laquelle R1 désigne un reste béhényle, R2 désigne R1 ou Mg, et m et n valent, indépendamment l'un de l'autre, 0 ou des nombres compris entre 1 et 10. Ces compositions se caractérisent par un haut pouvoir moussant et par une tolérance particulièrement bonne au niveau des muqueuses.
PCT/EP1996/004617 1995-11-02 1996-10-24 Preparations cosmetiques Ceased WO1997016167A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP96934806A EP0858320A1 (fr) 1995-11-02 1996-10-24 Preparations cosmetiques

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19540830A DE19540830A1 (de) 1995-11-02 1995-11-02 Kosmetische Zubereitungen
DE19540830.6 1995-11-02

Publications (1)

Publication Number Publication Date
WO1997016167A1 true WO1997016167A1 (fr) 1997-05-09

Family

ID=7776438

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1996/004617 Ceased WO1997016167A1 (fr) 1995-11-02 1996-10-24 Preparations cosmetiques

Country Status (3)

Country Link
EP (1) EP0858320A1 (fr)
DE (1) DE19540830A1 (fr)
WO (1) WO1997016167A1 (fr)

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0358216A2 (fr) * 1988-09-08 1990-03-14 Kao Corporation Composition détergente peu irritante
WO1991013960A1 (fr) * 1990-03-12 1991-09-19 Henkel Kommanditgesellschaft Auf Aktien Melanges tensio-actifs
EP0572776A1 (fr) * 1992-05-29 1993-12-08 Hüls Aktiengesellschaft Composition d'agent tensio-actifs épaississant par électrolyte
WO1994016676A1 (fr) * 1993-01-26 1994-08-04 Wella Aktiengesellschaft Produit d'hygiene capillaire et de soins corporels
DE4331297A1 (de) * 1993-09-15 1995-03-16 Henkel Kgaa Stückseifen
JPH07197079A (ja) * 1993-12-29 1995-08-01 Sunstar Inc 洗浄剤組成物
JPH07292386A (ja) * 1993-12-29 1995-11-07 Sunstar Inc 洗浄剤組成物
EP0681832A2 (fr) * 1994-05-11 1995-11-15 Hüls Aktiengesellschaft Solutions aqueuses et viscoélastiques d'agents tensioactifs pour le nettoyage de la peau et des cheveux
DE4435387A1 (de) * 1994-10-04 1996-04-11 Henkel Kgaa Pumpfähige wäßrige Tensidkonzentrate
EP0723004A1 (fr) * 1994-08-10 1996-07-24 Kao Corporation Composition detergente

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0358216A2 (fr) * 1988-09-08 1990-03-14 Kao Corporation Composition détergente peu irritante
WO1991013960A1 (fr) * 1990-03-12 1991-09-19 Henkel Kommanditgesellschaft Auf Aktien Melanges tensio-actifs
EP0572776A1 (fr) * 1992-05-29 1993-12-08 Hüls Aktiengesellschaft Composition d'agent tensio-actifs épaississant par électrolyte
WO1994016676A1 (fr) * 1993-01-26 1994-08-04 Wella Aktiengesellschaft Produit d'hygiene capillaire et de soins corporels
DE4331297A1 (de) * 1993-09-15 1995-03-16 Henkel Kgaa Stückseifen
JPH07197079A (ja) * 1993-12-29 1995-08-01 Sunstar Inc 洗浄剤組成物
JPH07292386A (ja) * 1993-12-29 1995-11-07 Sunstar Inc 洗浄剤組成物
EP0681832A2 (fr) * 1994-05-11 1995-11-15 Hüls Aktiengesellschaft Solutions aqueuses et viscoélastiques d'agents tensioactifs pour le nettoyage de la peau et des cheveux
EP0723004A1 (fr) * 1994-08-10 1996-07-24 Kao Corporation Composition detergente
DE4435387A1 (de) * 1994-10-04 1996-04-11 Henkel Kgaa Pumpfähige wäßrige Tensidkonzentrate

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 9539, Derwent World Patents Index; Class A96, AN 95-299834, XP002024220 *
DATABASE WPI Section Ch Week 9602, Derwent World Patents Index; Class A11, AN 96-017524, XP002024219 *

Also Published As

Publication number Publication date
DE19540830A1 (de) 1997-05-07
EP0858320A1 (fr) 1998-08-19

Similar Documents

Publication Publication Date Title
EP0910329B1 (fr) Concentres aqueux a lustre nacre
EP0942706B1 (fr) Concentres aqueux de lustre perlaire
WO1996004887A1 (fr) Melanges detergents moussants
EP0804280A1 (fr) Emulsifiants
EP0776658A1 (fr) Préparations cosmétiques et/ou pharmaceutiques à base de tensioactifs saccharides et de glycérides partiels d'acides gras
EP0910328B1 (fr) Concentres aqueux a lustre nacre
EP1002038B1 (fr) Concentres de lustre perlaire aqueux
EP0912700B1 (fr) Concentres aqueux de lustre nacre
EP0844867A1 (fr) Preparations cosmetiques contenant des lactylates acyliques, des hydrolysats proteiques et des condensats d'acide gras proteique
DE19622214A1 (de) Hydroxycarbonsäureester
EP0999822B1 (fr) Concentres aqueux nacres
EP0930872B1 (fr) Dispersions aqueuses de lustre perlaire
EP0858320A1 (fr) Preparations cosmetiques
WO1996029982A1 (fr) Preparations cosmetiques et/ou pharmaceutiques
DE19613203C2 (de) Tensidgemische
DE19732709C1 (de) Wäßrige Perlglanzkonzentrate
EP0866845A1 (fr) Savons en detergents synthetiques
EP0770607A1 (fr) Sorbitan esterquats et leur utilisation comme agents tensioactifs notamment pour des soins capillaires et des soins corporels
EP0797983A2 (fr) Utilisation des ethers méthyliques dans les compositions cosmétiques et/ou pharmaceutiques
EP0776653A1 (fr) Compositions cosmétiques et/ou pharmaceutiques contenant des amides d'acides gras polyhydroxyle

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1996934806

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1996934806

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97517042

Format of ref document f/p: F

WWW Wipo information: withdrawn in national office

Ref document number: 1996934806

Country of ref document: EP